Cancer
Liaison Program
Cancer News Releases: 2000 - present
2008
2007
2006
2005
2004
2003
2002
2001
- Maryland Businessman Sentenced
for Illegally Marketing Aloe Vera Compounds as AIDS and Cancer Treatments (December 5)
- FDA Alerts Southern Florida
Patients to Possibly Inadequate Prostate Cancer Treatments (November
27) The U.S. Food and Drug Administration is alerting certain prostate
cancer patients in South Florida to the possibility that they may have been
given inadequate levels of the anti-cancer drug Lupron. This alert applies
only to prostate cancer patients who have been treated at Urology P.A. --
operated by Dr. Victor Souaid at 2100 East Sample Road, Pompano Beach, Florida.
- Xeloda (capecitabine) from Roche and Taxotere (docetaxel) from Aventis, Inc. received approval
on September 10, 2001 for treating patients with metastatic breast cancer whose cancer has progressed after treatment with an anthracycline-containing
cancer therapy (such as Adriamycin and doxorubicin).
- Given Diagnostic Imaging
System, from Given Imaging Ltd, received approval on August 1, 2001, is a swallowable capsule containing a tiny camera that snaps pictures twice
a second as it moves through the small intestine. It is intended to
visualize the inside of the small intestine to detect polyps, cancer or causes
of bleeding and anemia.
- New Joint Program Announced
by FDA and NCI Holds Promise for Cancer Treatment (July 20) The
new program, called the Clinical Proteomics Program, melds the study of all
proteins in living cells (or proteomics) to the clinical care of patients,
the first time this new research technology has been applied directly to patient
care.
- Operation Cure All
Battle Internet Health Fraud, FDA has joined with the Federal Trade
Commission (FTC) and others in a program aimed at stopping Internet scams
that promote dietary supplements, devices, and other products as cures or
treatments for cancer and other life-threatening diseases. (June 14)
- FDA Approves Gleevec for Leukemia
Treatment (May 10)
- FDA Approves Femara as
First-Line Therapy for Advanced Breast Cancer (January 10)
2000
Cancer Liaison Program
Home Page